financetom
Business
financetom
/
Business
/
Hologic's Aptima SARS-CoV-2 Assay Receives FDA Clearance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hologic's Aptima SARS-CoV-2 Assay Receives FDA Clearance
Feb 18, 2025 6:02 AM

08:31 AM EST, 02/18/2025 (MT Newswires) -- Hologic ( HOLX ) said Tuesday that the US Food and Drug Administration has granted 510(k) clearance for its Aptima SARS-CoV-2 assay.

The company said the test can detect and quantify genetic sequences to determine if respiratory viral pathogens are present.

A 510(k) clearance allows a medical device to be marketed if it can demonstrate substantial equivalence to an existing approved device.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved